Feature Interviews
Breast Cancer:
|
|
|
|
| New treatment
for Breast Cancer: Tykerb (lapatinib) |
Prof. Dr. Michael Untch
Head of the Clinic for Gynecology, Gynecology, Oncology and Obstetrics, Head of Breast Cancer Center, Helios Klinikum Berlin-Buch, Academic Hospital of the University Charite, Berlin, Germany
|
June 2006
42nd Annual Meeting of the American Society of Clinical Oncology, Atlanta, Georgia
|
|
| Compliance
and Adherence, Herceptin |
Victor Vogel, MD
Director, Magee/UPCI Breast Cancer Prevention Program, University of
Pittsburgh School of Medicine, Professor of Medicine and Epidemiology,
Magee-Womens Hospital, Pittsburgh, PA
|
Dec 2005
San Antonio Breast Cancer Symposium
|
|
| Herceptin |
Edward Romond, MD
Associate Professor, Division of Hematology & Oncology, Department of
Internal Medicine, University of Kentucky Markey Cancer Center, Lexington,
KY
|
Dec 2005
San Antonio Breast Cancer Symposium
|
|
CellSearch,
Circulating tumor cells |
Fred Smith, MD
Medical Oncologist, Sibley Memorial Hospital, Georgetown University,
Washington DC |
Dec 2005
San Antonio Breast Cancer Symposium
|
|
| Herceptin |
Hope Rugo, MD
Clinical Professor of Medicine, Director of the Breast Oncology Clinical
Trials Program, University of California, San Francisco |
Dec 2005
San Antonio Breast Cancer Symposium
|
|
| Breast Cancer |
Martine Piccart, MD, PhD
Associate Professor, Head of the Medicine Department, Jules Bordet Institute, Burssels, Belgium |
Nov 2005
ECCO
Paris, France
|
|
| Metastatic
breast cancer - Clinical Trial on Lapatinib |
Kimberly Blackwell, MD
Assistant Professor of Medicine, Division of Hematology-Oncology, Duke University
Medical Center, Durham, NC |
December 2004
San Antonio Breast Cancer Symposium
|
|
| Predicting
response to chemotherapy & presence of metastatic disease in patients with breast
cancer |
Massimo Cristofanilli, MD
Assistant Professor of Medicine, Department of Breast Medical Oncology, MD Anderson
Cancer Center, Houston, TX |
December 2004
San Antonio Breast Cancer Symposium
|
|
| Prevention
Clinical Trial for Breast Cancer for post-menopausal women |
Paul Goss, MD
Director of Breast Cancer Research, Massachusetts General Hospital; Professor
of Medicine, Harvard Medical School, Boston, MA |
December 2004
San Antonio Breast Cancer Symposium
|
|
| General discussion
on aromatase inhibitors for early stage breast cancer |
William Gradishar, MD, FACP
Director of Breast Medical Oncology, Associate Professor of Medicine, Co-Director,
Lynne Sage Breast Cancer Program, Robert H. Lurie Comprehensive Cancer Center,
Chicago, IL |
December 2004
San Antonio Breast Cancer Symposium
|
|
| Aromatase
inhibitors, hormonal management of breast cancer discussion, including Arimidex
(Anastrazole) and ATAC trial (Arimidex & Tamoxifen: Alone or in combination) |
Generosa Grana, MD
Head, Division of Hematology & Medical Oncology, Cooper University Hospital; Associate
Professor of Medicine, Robert Wood Johnson Medical School; Adjunct Assistant Professor,
Coriell Institute for Medical Research, Camden, NJ |
December 2004
San Antonio Breast Cancer Symposium
|
|
| Aromatase
inhibitors focusing on Aromasin for breast cancer |
Stephen Jones, MD
Medical Director, US Oncology Research; Chair, Breast Cancer Research Committee,
US Oncology, Dallas, TX |
December 2004
San Antonio Breast Cancer Symposium
|
|
| Overview
of 27th Annual San Antonio Breast Cancer Symposium Symposium |
C. Kent Osborne, MD
Director, Breast Center at Baylor College of Medicine; Professor of Medicine and
Cellular & Structural Biology; Director, Baylor Cancer Center, Houston, TX |
December 2004
San Antonio Breast Cancer Symposium
|
|
| MA-17 Femara
(Letrozole) study |
Victor Vogel, MD, MHS, FACP
Director, Magee/UPCI Breast Cancer Prevention Program, Professor of Medicine &
Epidemiology, University of Pittsburgh School of Medicine, Magee Women's Hospital,
Pittsburgh, PA |
December 2004
San Antonio Breast Cancer Symposium
|
|
| Overview
of the 2nd Interamerican Breast Cancer Conference |
Eli Avisar, MD
Assistant Professor of Clinical Surgery, Co-Leader, Breast Site Disease Group,
University of Miami School of Medicine, Miami, FL |
July 2004
Cancun, Mexico
|
|
| History and
Description of Aromatase inhibitors |
Craig Henderson, MD
Adjunct Prof. of Medicine at the University of California San Francisco |
June 2004
ASCO
New Orleans, LA
|
|
| Aromatase inhibitors, focusing on Aromasin as treatment for breast cancer |
Per Lonning, MD, PhD
Head of the Breast Section Department of Oncology at Hockland University Hospital, Bergen, Norway |
June 2004
ASCO
New Orleans, LA
|
|
| Combination breast cancer treatment trial including herceptin with taxol and carboplatnin |
Nicholas Robert, MD
Fairfax Northern Virginia Hematology Oncology |
June 2004
ASCO
New Orleans, LA
|
|
| Scheduling of treatment of taxol for metastatic breast cancer |
Andrew Seidman, MD
Associate Attending for the Breast Cancer Mdeicine Service, Memorial Sloan-Kettering Cancer Center and an
Associate Prof. of Medicine Weill Medical College of Cornell University
|
June 2004
ASCO
New Orleans, LA
|
|
| Self-Breast Exam |
Anne Appleton, MD
Médecin-Chef de l'Unité de Sénologie, Clinique de Genolier
Stefan Gluck, MD, PhD
Professor, Division of Hematology/Oncology, University of Miami Sylvester Cancer Center |
March 2004
EBCC
Hamburg, Germany
|
|
| Cancer de sein |
Anne Appleton, MD
Médecin-Chef de l'Unité de Sénologie, Clinique de Genolier |
March 2004
EBCC
Hamburg, Germany
|
|
| Breast cancer program at the University of Miami, Florida |
Stefan Gluck, MD, PhD
Professor, Division of Hematology/Oncology, University of Miami Sylvester Cancer Center |
March 2004
EBCC
Hamburg, Germany
|
|
| Breast cancer treatment - Ellence (Epirubicin) |
Stefan Gluck, MD, PhD
Professor, Division of Hematology/Oncology, University of Miami Sylvester Cancer Center |
March 2004
EBCC
Hamburg, Germany
|
|
| Breast cancer |
Fritz Jänicke, MD, PhD
Chairman & Senior Professor for Obstetrics & Gynecology, University of Hamburg, Eppendorf |
March 2004
EBCC
Hamburg, Germany
|
|
| Significance of breast cancer treatment related fatigue |
Lonneke van de Poll-Franse, MD, PhD
Senior Researcher, Comprehensive Cancer Center South, Eindhoven, Netherlands |
March 2004
EBCC
Hamburg, Germany
|
|
| Adjuvant treatment for breast cancer |
Peter Barrett-Lee, MD
Oncologist, Velindre VHS Trust, Velindre Hospital, Cardiff, Wales |
June 2, 2003
ASCO
Chicago
|
|
| Male breast cancer |
Peter Barrett-Lee, MD
Oncologist, Velindre VHS Trust, Velindre Hospital, Cardiff, Wales |
June 2, 2003
ASCO
Chicago
|
|
| Cancer treatment-related fatigue in regard to treatment for breast cancer |
Julie Gralow, MD
Associate Professor, University of Washington School of Medicine
Seattle, WA
|
June 2, 2003
ASCO
Chicago
|
|
| Cancer treatment-related fatigue in regard to treatment for breast cancer |
Clifford Hudis, MD
Chief, Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY |
June 2, 2003
ASCO
Chicago
|
|
| Breast cancer advances in the UK |
Michael Richards, MD, PhD
National Cancer Director, NHS Executive, Department of Palliative Medicine, St. Thomas' Hospital, London, UK |
June 2, 2003
ASCO
Chicago
|
|
| Hormonal Therapy for Breast Cancer (2 tracks) |
Matthew Ellis, MD, PhD, FRCP
Director, Breast Cancer Program, Duke Comprehensive Cancer Center, Durham, NC |
May 29, 2003
ASCO
Chicago
|
|
| Combination therapy & metastatic breast cancer |
Denise Yardley, MD
Director of Breast Cancer Research, The Sarah Cannon Cancer Center, Nashville, TN |
May 29, 2003
ASCO
Chicago
|
|
| Die Optimierung von Hämoglobinwerten und darüber hinaus: Kraft zum Leben und bedeutsamen Überleben? |
Ursula Goldman-Posch
Mamazone, Frauen und Forschung gegen Brustkrebs e.V. |
March 20, 2003
Vienna, Austria
|
|
|
|
|
|
| |
|
Cancer Treatment-Related Fatigue
and Anemia:
|
|
|
|
| Cancer-related
fatigue and anemia |
Roger Waltzman, MD
Assistant Prof. Dept. of Medicine, Section of Medical Oncology & Section of Palliative
Medicine, St. Vincent's Hospital in New York City |
June 2004
ASCO
New Orleans
|
|
| Cancer-related
fatigue and anemia in regards to treatment for breast cancer. |
Lonneke van de Poll-Franse,
MD, PhD
Senior Researcher, Comprehensive Cancer Center South, Eindhoven, Netherlands |
March 2004
EBCC
Hamburg, Germany
|
|
| European
Cancer Anemia Survey (ECAS) |
Peter Barrett-Lee, MD
Oncologist, Velindre VHS Trust, Velindre Hospital, Cardiff, Wales |
June 2, 2003
ASCO
Chicago
|
|
| Die Optimierung
von Hämoglobinwerten und darüber hinaus: Kraft zum Leben und bedeutsamen Überleben?
|
Jens-Uwe Blohmer, MD, PhD
Humboldt University, Berlin, Germany |
March 20, 2003 Vienna, Austria
|
|
| Cancer-related
fatigue and anemia in regards to treatment |
Pere Gascon, MD, PhD
Director, Division of Medical Oncology Instituto de Enfermedades Hemato-Oncológicas
Barcelona, Spain |
March 20, 2003 Vienna, Austria
|
|
| Die Optimierung
von Hämoglobinwerten und darüber hinaus: Kraft zum Leben und bedeutsamen Überleben? |
Ursula Goldman-Posch
Mamazone, Frauen und Forschung gegen Brustkrebs e.V. |
March 20, 2003 Vienna, Austria
|
|
| Cancer-related
fatigue and anemia |
Paul Harrison
Cancer patient |
March 21, 2003 Vienna, Austria
|
|
| Cancer-related
fatigue, doctor/patient communication, quality of life |
Paul Harrison &
Timothy Littlewood, MD
John Radcliffe Hospital, Oxford, United Kingdom |
March 21, 2003 Vienna, Austria
|
|
| Die Optimierung
von Hämoglobinwerten und darüber hinaus: Kraft zum Leben und bedeutsamen Überleben? |
Uwe Reinhardt, MD, PhD
Medizinische Klinik I, Hämatologie und Onkologie, Klinikum Bayreuth, Deutschland |
March 20, 2003 Vienna, Austria
|
|
| Cancer-related
fatigue and anemia in regards to the treatment of gynecologic cancers. |
Maurice Schneider, MD, PhD
Professor in Medical Oncology at the Faculty of Medicine, Centre Antoine Lacassagne,
Nice, France |
March 20, 2003 Vienna, Austria
|
|
| Die Optimierung
von Hämoglobinwerten und darüber hinaus: Kraft zum Leben und bedeutsamen Überleben?
|
Hans-Joachim Schmoll, MD,
PhD
Direktor der Klinik und Poliklinik für Innere Medizin IV - Hämatologie/ Onkologie,
Martin-Luther-Universität Halle-Wittenberg; Generalsekretär, Vital Options International,
Deutschland |
March 20, 2003 Vienna, Austria
|
|
| Cancer-related
fatigue and anemia in regards to treatment for gastrointestinal cancers. |
Dirk Schrijvers, MD
Medical Oncologist, Middelheim Hospital, Antwerp, Belgium, and Chair of the ESMO
Education and Training Committee |
March 21, 2003 Vienna, Austria
|
|
| Au delà d'améliorer
les niveaux d'hémoglobine: Le pouvoir de vie et de survie significative? |
Simon van Belle, MD, PhD
Department of Internal Medicine, University Hostpial Gent, Belgium |
March 20, 2003 Vienna, Austria
|
|
|
|
|
|
| |
|
Doctor-Patient Communication:
|
|
|
|
| Doctor/Patient Communication and Information Exchange |
Paul Cornes, MD
Medical Oncologist, Clinical Oncology Research, Bristol Oncology Centre, United Kingdom |
October 2004
ESMO
Vienna, Austria
|
|
| Cancer-related fatigue, doctor/patient communication, quality of life. |
Paul Harrison &
Timothy Littlewood, MD
John Radcliffe Hospital, Oxford, United Kingdom
Senior Researcher, Comprehensive Cancer Center South, Eindhoven, Netherlands |
March 21, 2003
Vienna, Austria
|
|
|
|
|
|
| |
|
Gastrointestinal Cancers - Colorectal,
Liver, Pancreatic:
|
|
|
|
| Innovative Technology in the Treatment of Cancers Affecting the Liver |
Hans-Joachim Schmoll, MD,
PhD
Director of the University Hospital for Internal Medicine IV, Hematology and Oncology,
Martin Luther University Halle, Germany; Chairman of the German Association of
Medical Oncology; President of the Cancer Society of the German State of Saxsen-Anhalt;
General Secretary of Vital Options International, Germany |
May 2005
ASCO
Orlando, FL
|
|
| Colorectal
Cancer ESMO 2004 Meeting Overview |
Roberto Labianca, MD, PhD
MOSES Working Group |
June 2004
ASCO
New Orleans
|
|
| Pancreatic
cancer |
Roberto Labianca, MD, PhD
MOSES Working Group |
June 2004
ASCO
New Orleans
|
|
| Colorectal
cancer |
Hans-Joachim Schmoll, MD,
PhD
Director of the University Hospital for Internal Medicine IV, Hematology and Oncology,
Martin Luther University Halle, Germany; Chairman of the German Association of
Medical Oncology; President of the Cancer Society of the German State of Saxsen-Anhalt;
General Secretary of Vital Options International, Germany |
June 2004
ASCO
New Orleans
|
|
| Colorectal
cancer update |
Hans-Joachim Schmoll, MD,
PhD
Director of the University Hospital for Internal Medicine IV, Hematology and Oncology,
Martin Luther University Halle, Germany; Chairman of the German Association of
Medical Oncology; President of the Cancer Society of the German State of Saxsen-Anhalt;
General Secretary of Vital Options International, Germany |
June 2003
ESEC
Edinburgh, Scotland
|
|
| Colorectal
cancer, MOSAIC study |
Aimery de Gramont, MD, PhD
Service de Médicine Interne-Oncologie, Hôpital Saint-Antoine Paris, France |
June 2, 2003
ASCO
Chicago
|
|
| Colorectal
cancer |
Clare Topham, MD
Consultant, Clinical Oncology, NHS Trust, St. Luke's Cancer Center, Royal Surrey
County Hospital & Mount Alvernia Hosptial Surrey, UK |
June 2, 2003
ASCO
Chicago
|
|
| Die Optimierung
von Hämoglobinwerten und darüber hinaus: Kraft zum Leben und bedeutsamen Überleben?
|
Hans-Joachim Schmoll, MD,
PhD
Direktor der Klinik und Poliklinik für Innere Medizin IV - Hämatologie/ Onkologie,
Martin-Luther-Universität Halle-Wittenberg; Generalsekretär, Vital Options International,
Deutschland |
March 20, 2003 Vienna, Austria
|
|
| Cancer-related
fatigue and anemia in regards to treatment for gastrointestinal cancers. |
Dirk Schrijvers, MD
Medical Oncologist, Middelheim Hospital, Antwerp, Belgium, and Chair of the ESMO
Education and Training Committee |
March 21, 2003 Vienna, Austria
|
|
|
|
|
|
| |
|
Genetics:
|
|
|
|
| Gynecologic cancer |
Agustin Garcia, MD
Director of Breast Cancer Research at the Women's Cancer Research Institute at Cedars-Sinai Medical Center, Los Angeles, CA |
October 3, 2004
|
|
| Counseling for genetic testing |
Talia Donnenberg
Board Certified Genetic Counselor, University of Miami School of Medicine, Sylvester Comprehensive Cancer Center |
July 2004
2nd Interamerican Breast Cancer
Conference
Cancun, Mexico
|
|
|
|
|
|
| |
|
Gynecologic Cancers:
|
|
|
|
| Gynecologic cancer update |
Sergio Pecorelli, MD, PhD
Professor of Gynecologic Oncology, Chairman, Dept. of Obstetrics and Gynecology University of Brescia Brescia, Italy |
June 2004
ASCO
New Orleans
|
|
| Recurrent ovarian cancer |
Peter Rose, MD
Professor, Department of Obstetrics and Gynecology, MetroHealth Medical Center, Cleveland, OH |
May 29, 2003
ASCO
Chicago
|
|
| Cancer-related fatigue and anemia in regards to the treatment of gynecologic cancers. |
Maurice Schneider, MD, PhD
Professor in Medical Oncology at the Faculty of Medicine, Centre Antoine Lacassagne, Nice, France |
March 20, 2003
Vienna, Austria
|
|
|
|
|
|
| |
|
Leukemia/Lymphoma:
|
|
|
|
| Lymphoma & multiple myeloma |
John Leonard, MD
Assistant Professor of Medicine, Assistant Attending Physician, Department of Hematology/Oncology, New York Weill Cornell Medical Center, New York, NY |
June 2004
ASCO
New Orleans
|
|
| Lymphoma |
John Leonard, MD
Assistant Professor of Medicine, Assistant Attending Physician, Department of Hematology/Oncology, New York Weill Cornell Medical Center, New York, NY |
June 2, 2003
ASCO
Chicago
|
|
|
|
|
|
| |
|
Lung Cancer:
|
|
|
|
| Lung Cancer |
Christian Manegold, MD, PhD
Professor of Medicine, Interdisciplinatry Thoracic Oncology, Department of Surgery, Heidelberg University, Mannheim, Germany |
Nov 2005
ECCO
Paris, France
|
|
| Lung cancer |
Ronald Natale, MD
Senior Research Advisor, Salick Health Care, Inc., Cedars-Sinai Comprehensive Cancer Center, Los Angeles, CA |
June 2004
ASCO
New Orleans
|
|
| Lung cancer |
Nasser Hanna, MD
Assistant Professor, Department of Medicine, Division of Hematology/Oncology, University of Indiana, Indianapolis, IN |
June 2, 2003
ASCO
Chicago
|
|
|
|
|
|
| |
|
Multiple Myeloma:
|
|
|
|
| Lymphoma
& multiple myeloma |
John Leonard, MD
Assistant Professor of Medicine, Assistant Attending Physician, Department of
Hematology/Oncology, New York Weill Cornell Medical Center, New York, NY |
June 2004
ASCO
New Orleans
|
|
|
|
|
|
| |
|
Prostate Cancer:
|
|
|
|
| Targeted
Therapy for Prostate Cancer |
Michael Carducci, MD
Associate Professor in Oncology and Urology, James Buchanan Brady Urological
Institute, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medical
Institutions, Baltimore, MD
|
May 2005
ASCO
Orlando, FL
|
|
|
|
|
|
| |
|
Supportive Care:
|
|
|
|
| Palliative
Care |
Raphael Catane, MD, PhD
Chairman, Department of Oncology, Sheba Medical Center, Tel-Hashomer, Israel
Nathan Cherny, MD, PhD
Director, Cancer Pain & Palliative Medicine Service, Department of Oncology, Shaare
Zedek Medical Center, Jerusalem, Israel |
October 2004
ESMO
Vienna, Austria
|
|
| Complementary
& Alternative Medicine |
Patrick Mansky, MD
University Witten Herdecke Medical School, Memorial Sloan Kettering Cancer Center,
NY; Metro Health Med. Ctr, CWRU, Cleveland, OH; Natl. Cancer Institute, NIH |
June 2004 ASCO, New Orleans
|
|
|
|
|
|
| |
|
Urinary Cancer:
|
|
|
|
| Adjuvant chemotherapy for bladder cancer |
Anthony El-Khoureiry, MD
Clinical Instruction of Medicine, Division of Medical Oncology, USC Norris Comp. Cancer Center |
June 2004
ASCO
New Orleans
|
|
|
|
|
|
| |
|
American Society of Clinical Oncology
(ASCO):
|
|
|
|
| New treatment
for Breast Cancer: Tykerb (lapatinib) |
Prof. Dr. Michael Untch
Head of the Clinic for Gynecology, Gynecology, Oncology and Obstetrics, Head of Breast Cancer Center, Helios Klinikum Berlin-Buch, Academic Hospital of the University Charite, Berlin, Germany
|
June 2006
42nd Annual Meeting of the American Society of Clinical Oncology, Atlanta, Georgia
|
|
| ASCO Overview and Introduction, Situation in France |
Claude-Alain Planchon, MD
Département de Médicine Nucléaire, The American Hospital of Paris; Secrétaire Général, Vital Options International & Choix Vital, France |
June 2004
ASCO
New Orleans
|
|
|
|
|
|
| |
|
C-Change 2007 Annual Meeting:
|
|
|
|
Right
to rehab for cancer patients; Quality of life/functioning after cancer; Cancer
as a chronic disease
|
Paul
Barnes
CEO, Navitas Cancer Rehabilitation Centers |
October 2007
Washington, DC
|
|
| Patient
care & pain management |
Pamela
Bennett, RN, BSN
Executive Director, Healthcare Alliance Development, Purdue Pharma, LP; Past-President,
American Society for Pain Management Nursing |
October 2007
Washington, DC
|
|
Public
messaging: anti-smoking, nutrition, physical activity; Reaching underserved communities
|
Peggy
Conlon
President & CEO, Advertising Council, Inc |
October 2007
Washington, DC
|
|
Patient
care & oncology nursing: the role of the oncology nurse; Symptoms / symptom
management
|
Georgia
Decker, RN
President, Oncology Nursing Society
Paula Rieger, RN
Chief Executive Officer, ONS |
October 2007
Washington, DC
|
|
Caregiving
& patient advocacy for rare cancers, esp. gall bladder; Psychosocial issues
with rare cancer patients; Doctor/Advocacy group connections
|
Amy
Dockser-Marcus
Staff Health Reporter, The Wall Street Journal; Recipient of Robert Wood Johnson
Foundation Health Investigator Award for research on rare cancers |
October 2007
Washington, DC
|
|
| Cervical
cancer prevention |
Katherine
Guccione
Manager, Public Policy and PR, Women in Government |
October 2007
Washington, DC
|
|
Cancer
prevention research; Chemo prevention, cancer vaccines
|
Ronald
Herberman, MD
Director, University of Pittsburgh Cancer Institute; Chair, C-Change Research
Team |
October 2007
Washington, DC
|
|
Prevention
and cancer control; Tobacco and disease prevention in Texas
|
Philip
Huang
Medical Director of Chronic Disease Prevention, Texas Department of State Health
Services; President-Elect of the National Association of Chronic Disease Directors |
October 2007
Washington, DC
|
|
Shortage
of oncologists; Policy barriers to growing oncology workforce
|
Maureen
Lichtveld, MD, MPH
Professor & Chair, Freeport McMoRan Chair of Environmental Policy; Associate Director,
Louisiana Cancer Research Consortium |
October 2007
Washington, DC
|
|
| Cancer
prevention |
James
Marks, MD, MPH
Senior Vice President & Director, Health Group, Robert Wood Johnson Foundation;
Vice-Chairman, C-Change Board of Directors |
October 2007
Washington, DC
|
|
| Compliance
and side-effects |
Martin
Murphy, Jr., PhD
Convener, CEO Roundtable on Cancer, Inc. |
October 2007
Washington, DC
|
|
| Tobacco
and smoking: countering the tobacco industry |
Matthew
Myers, JD
President, Campaign for Tobacco-Free Kids |
October 2007
Washington, DC
|
|
| Biomarker
research development program |
Clet
Niyikiza, MD
Vice President, Strategy Asset Management, GlaxoSmithKline |
October 2007
Washington, DC
|
|
What
is an actuary?
- Chemo prevention
- Patient navigation
|
Bruce
Pyenson
Principal & Consulting Actuary, Milliman, Inc. |
October 2007
Washington, DC
|
|
Detection
and prevention; Access to medication
|
Gary
Reedy
Worldwide Vice President, Biopharmaceutical Public Policy, Johnson & Johnson,
C-Change Board Member |
October 2007
Washington, DC
|
|
Patient
care and oncology social work; Side-effects; Navigating support options; POWER
- Psychosocial Oncology Worldwide Education Resource; Social worker network
|
Kathryn
Smolinski, MSW
Executive Director, Association of Oncology Social Work
Marcia DeSonier, MSW
President-Elect, AOSW |
October 2007
Washington, DC
|
|
Comprehensive
cancer control; Distribution of physicians and centers / access to care; Physician
collaboration
|
George
Weiner, MD
Director, Holden Comprehensive Cancer Center |
October 2007
Washington, DC
|
|
Social
barriers to men & proactive with health; Smoking and lung cancer, prostate
cancer; "Get it checked" campaign; All men's health issues, not just
cancer
|
Scott
Williams
Director, Professional Relations & Public Policy, Men's Health Network |
October 2007
Washington, DC
|
|
Comprehensive
cancer and health literacy; Children and young adults / prevention; Early detection;
High school dropout rate and college enrollment levels
|
Governor
Bob Wise
President, Alliance for Excellent Education |
October 2007
Washington, DC
|
|
| Clinical
Trials |
Robert
Young, MD
Chancellor, Fox Chase Cancer Center |
October 2007
Washington, DC
|
|
|
|
|
|
| |
|
European Cancer Conference
(ECCO):
|
|
|
|
| ECCO |
Harry Bartelink, MD, PhD
President of the Federation of European Cancer Societies (FECS) and the European
Cancer Conference (ECCO); Professor and Chairman, Division of RadioTherapy, The
Netherlands Cancer Institute, Anton van Leeuwenhoek Hospital, Amsterdam, Netherlands
|
Nov 2005
ECCO
Paris, France
|
|
| ECCO |
Michael C.G. Stevens, MD, PhD
Royal Hospital for Children, Division of Child Health, Bristol, United Kingdom
|
Nov 2005
ECCO
Paris, France
|
|
| Lung Cancer |
Christian Manegold, MD, PhD
Professor of Medicine, Interdisciplinatry Thoracic Oncology, Department of Surgery, Heidelberg University, Mannheim, Germany |
Nov 2005
ECCO
Paris, France
|
|
| ECCO |
Luigi Cataliotti, MD, PhD
President, European Society of Mastology; President, Surgery Department, University of Florence, Florence, Italy |
Nov 2005
ECCO
Paris, France
|
|
| Breast Cancer |
Martine Piccart, MD, PhD
Associate Professor, Head of the Medicine Department, Jules Bordet Institute, Burssels, Belgium |
Nov 2005
ECCO
Paris, France
|
|
|
|
|
|
| |
|
European Society of Medical Oncology
(ESMO):
|
|
|
|
| ESMO |
Gunta Purkalne, MD
Head, Radiation & Chemotherapy Centre, Stradins University Hospital, Riga,
Latvia
|
May 2005
ASCO
Orlando, FL
|
|
| ESMO |
Håkan Mellstedt, MD
President-Elect, European Society for Medical Oncology (ESMO); Professor of
Oncologic Bioterapy
Administrative Director, CancerCenter Karolinska; Chief Physician,
Department of Oncology, Division of Oncologic Biotherapy, Karolinska
Institutet, Stockholm, Sweden
|
May 2005
ASCO
Orlando, FL
|
|
| ESMO Meeting,
General Discussion |
Paul Cornes, MD
Medical Oncologist, Clinical Oncology Research, Bristol Oncology Centre, United
Kingdom |
October 2004
ESMO
Vienna, Austria
|
|
| Global Core
Curriculum in Medical Oncology |
Heine H. Hansen, MD, PhD
Professor, Finsen Centre, National University Hospital, Copenhagen, Denmark |
October 2004
ESMO
Vienna, Austria
|
|
| Overview
of ESMO Meeting |
Heinz-Josef Lenz, MD
Associate Professor of Medicine and Preventive Medicine, Director, Colorectal
Center and GI Oncology Program, USC/Norris Comprehensive Cancer Center, Los Angeles,
CA |
October 2004
ESMO
Vienna, Austria
|
|
| Minimum Clinical
Recommendations |
Rolf Stahel, MD, PhD
Department of Oncology, University Hospital, Zurich, Switzerland |
October 2004
ESMO
Vienna, Austria
|
|
| ESMO and
the Cancer Patients |
Mario Dicato, MD, PhD
Departmental Head, Centre Hospitalier de Luxembourg |
June 2004
ASCO
New Orleans
|
|
| ESMO Patient Congress |
Paris Kosmidis, MD
President of the European Society for Medical Oncology (ESMO)
Head of the Second Medical Oncology Dept., Hygeia Hospital, Athens, Greece
|
June 2004
ASCO
New Orleans
|
|
| ESMO, colorectal cancer |
Roberto Labianca, MD, PhD
MOSES Working Group |
June 2004
ASCO
New Orleans
|
|
| ESMO Patient Congress |
Heinz Ludwig, MD, PhD
Head of the Department of Internal Medicine and Medical Oncology, Wilhelminen Hospital in Vienna, Chairman of the European Society for Medical Oncology (ESMO) Foundation and past president of ESMO |
June 2004
ASCO
New Orleans
|
|
| Organization of European Cancer Institutes (OECI) |
Mahasti Saghatchian, MD
Service Medical Oncology, Hospital George-Pompidou European, Paris |
June 2004
ASCO
New Orleans
|
|
|
|
|
|
| |
|
International Patient Issues:
|
|
|
|
| ASCO Overview and Introduction, Situation in France |
Claude-Alain Planchon, MD
Département de Médicine Nucléaire, The American Hospital of Paris; Secrétaire Général, Vital Options International & Choix Vital, France |
June 2004
ASCO
New Orleans
|
|
| Donner la voix aux patients |
Roland Bugat, MD
Istitut Claudius Regaud, Centre Regional de Lutte Contre Le Cancer Midi-Pyrenees, Toulouse
Mario Dicato, MD, PhD
Departmental Head Centre Hospitalier de Luxembourg |
June 2, 2003
ASCO
Chicago
|
|
| The need for cancer talk in Spain |
Pere Gascon, MD, PhD
Director, Division of Medical Oncology Instituto de Enfermedades Hemato-Oncológicas Barcelona, Spain |
June 2, 2003
ASCO
Chicago
|
|
| The need for cancer talk in Italy |
Sergio Pecorelli, MD, PhD
Professor of Gynecologic Oncology, Chairman, Dept. of Obstetrics and Gynecology University of Brescia Brescia, Italy |
June 2, 2003
ASCO
Chicago
|
|
|
|
|
|
| |
|
San Antonio Breast Cancer Symposium:
|
|
|
|
| Compliance
and Adherence, Herceptin |
Victor Vogel, MD
Director, Magee/UPCI Breast Cancer Prevention Program, University of
Pittsburgh School of Medicine, Professor of Medicine and Epidemiology,
Magee-Womens Hospital, Pittsburgh, PA
|
Dec 2005
San Antonio Breast Cancer Symposium
|
|
| Herceptin |
Edward Romond, MD
Associate Professor, Division of Hematology & Oncology, Department of
Internal Medicine, University of Kentucky Markey Cancer Center, Lexington,
KY
|
Dec 2005
San Antonio Breast Cancer Symposium
|
|
CellSearch,
Circulating tumor cells |
Fred Smith, MD
Medical Oncologist, Sibley Memorial Hospital, Georgetown University,
Washington DC |
Dec 2005
San Antonio Breast Cancer Symposium
|
|
| Herceptin |
Hope Rugo, MD
Clinical Professor of Medicine, Director of the Breast Oncology Clinical
Trials Program, University of California, San Francisco |
Dec 2005
San Antonio Breast Cancer Symposium
|
|
|
|
|
|
| |
|
World Health Organization (WHO):
|
|
|
|
| World Health Organization (WHO) Cancer Treaty |
Andreas Ulrich, MD, PhD
Medical Officer, Cancer Control Program, World Health Organization, Geneva, Switzerland |
ESMO 2004
Vienna, Austria
|
|
|
|
|
|
| |
|
|
|
